title: κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
abstract: Opioid receptors, members of the G-protein-coupled receptor superfamily, appear to be involved in cancer progression. However, the expression and significance of opioid receptors in esophageal squamous cell carcinoma (ESCC) remain unclear. In this study, we demonstrated by flow cytometry that μ, δ, and κ-opioid receptors (MOR, DOR, and KOR) are expressed to various degrees in ESCC cell lines. The KOR protein was further examined by several methods in ESCC cell lines and tissues. Immunocytochemical staining localized KOR to the cell membrane in KYSE180 cells and the nucleus in EC109 cells, whereas no signal or weak staining of the cytoplasm was observed in KYSE150 cells. The expression of KOR was confirmed in ESCC cells by Western blotting. Furthermore, immunohistochemistry staining showed that KOR was up-regulated in ESCC tissues compared with nontumorous esophageal epithelium (P = .004, χ(2) test). Moreover, high nuclear KOR expression was significantly correlated with lymph node metastasis in 256 ESCC cases (R = 0.144; P = .030, Kendall τB test). Patients with high nuclear KOR expression in ESCC had a significantly poorer prognosis (P = .001, log-rank test). Multivariate Cox analysis revealed that KOR in the nucleus was an independent prognostic factor (hazard ratio, 1.789; 95% confidence interval, 1.177-2.720; P = .006). Our results suggest that KOR is involved in the carcinogenesis or progression of ESCC and that nuclear KOR may be indicative of prognosis.
authors.affiliation: Institute of Oncologic Pathology, Medical College of Shantou University, Shantou 515041, PR China.
authors.forename: Yong-Fa
authors.initials: YF
authors.lastname: Zhang
authors.forename: Qing-Xia
authors.initials: QX
authors.lastname: Xu
authors.forename: Lian-Di
authors.initials: LD
authors.lastname: Liao
authors.forename: Xiu-E
authors.initials: XE
authors.lastname: Xu
authors.forename: Jian-Yi
authors.initials: JY
authors.lastname: Wu
authors.forename: Jian
authors.initials: J
authors.lastname: Shen
authors.forename: Zhi-Yong
authors.initials: ZY
authors.lastname: Wu
authors.forename: Jin-Hui
authors.initials: JH
authors.lastname: Shen
authors.forename: En-Min
authors.initials: EM
authors.lastname: Li
authors.forename: Li-Yan
authors.initials: LY
authors.lastname: Xu
mesh_terms: D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000401:mortality / Q000556:secondary*; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism / Q000473:pathology*; D002681:China / Q000453:epidemiology; D004938:Esophageal Neoplasms / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D016016:Proportional Hazards Models; D017473:Receptors, Opioid, kappa / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D017473:Receptors, Opioid, kappa
keywords: DOR; ERK; ESCC; G-protein–coupled receptors; GPCRs; GSK3β; KOR; MAP kinase; MAPK; MOR; NSCLC; OS; PI3K; Survival; TMA; TNM; esophageal squamous cell carcinoma; extracellular regulated protein kinase; glycogen synthase kinase-3beta; non–small cell lung cancer; overall survival; phosphatidylinositol-3 kinase; tissue microarray; tumor-node-metastasis; δ-opioid receptor; κ-Opioid receptor; κ-opioid receptor; μ-opioid receptor